Intelligent Medicine Acquisition Corp (IQMD)
$11.04
$0.00 (0.00%)As on 10-May-2023 09:30EDT
Market cap
$65 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
23
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$7 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
690,139
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Intelligent Medicine Acquisition Corp (IQMD)
| 7.4 | 7.2 | 7.7 | 10.4 | -- | -- | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Intelligent Medicine Acquisition Corp (IQMD)
|
11.0 | 64.8 | 0.0 | 9.9 | -- | 4.9 | 23 | 0.0 |
| 10.2 | 225.7 | 0.0 | 5.6 | -- | 3.2 | 40.7 | 1.3 | |
| 10.6 | 303.3 | 0.0 | 3.9 | -- | 1.7 | 263.8 | 0.0 | |
| 10.6 | -- | 0.0 | 5.2 | -- | 2.2 | -- | 0.0 |
Shareholding Pattern
View DetailsAbout Intelligent Medicine Acquisition Corp (IQMD)
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more... businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland. Read more
-
CEO, CFO & Director
Mr. Gregory C. Simon
-
CEO, CFO & Director
Mr. Gregory C. Simon
-
Headquarters
Bethesda, MD
-
Website
--
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Intelligent Medicine Acquisition Corp (IQMD)
What is the current share price of Intelligent Medicine Acquisition Corp (IQMD) Today?
The share price of Intelligent Medicine Acquisition Corp (IQMD) is $11.04 (NASDAQ) as of 10-May-2023 09:30 EDT. Intelligent Medicine Acquisition Corp (IQMD) has given a return of 10.4% in the last 1 years.
What is the current PB & PE ratio of Intelligent Medicine Acquisition Corp (IQMD)?
The P/E ratio of Intelligent Medicine Acquisition Corp (IQMD) is 23.00 times as on 10-May-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-- |
-- |
2021 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
What is the 52 Week High and Low of Intelligent Medicine Acquisition Corp (IQMD)?
The 52-week high and low of Intelligent Medicine Acquisition Corp (IQMD) are Rs -- and Rs -- as of 06-Sep-2026.
What is the market cap of Intelligent Medicine Acquisition Corp (IQMD)?
Intelligent Medicine Acquisition Corp (IQMD) has a market capitalisation of $ 65 Mln as on 10-May-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in Intelligent Medicine Acquisition Corp (IQMD)?
Before investing in Intelligent Medicine Acquisition Corp (IQMD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.